1 Institute of Oncology Research (IOR), Oncology Institute of Southern Switzerland (IOSI), CH6500, Bellinzona, Switzerland.
2 Università della Svizzera Italiana, CH6900, Lugano, Switzerland.
3 Bioinformatics Core Unit, Swiss Institute of Bioinformatics, TI, 6500, Bellinzona, Switzerland.
4 Faculty of Biology and Medicine, University of Lausanne UNIL, CH1011, Lausanne, Switzerland.
5 Institute of Molecular Health Sciences, ETH Zurich, CH8093, Zurich, Switzerland.
6 Massachusetts General Hospital Cancer Center, Harvard Medical School, Charlestown, MA, 02129, USA.
7 Department of Medicine, Division of Nephrology, Ente Ospedaliero Cantonale, Lugano, Switzerland.
8 Laboratories for Translational Research, Ente Ospedaliero Cantonale, Bellinzona, Switzerland.
9 Computational Oncology Unit, Department of Oncology, Istituto di Ricerche Farmacologiche 'Mario Negri' IRCCS, 20156, Milano, Italy.
10 Institute of Oncology Research (IOR), Oncology Institute of Southern Switzerland (IOSI), CH6500, Bellinzona, Switzerland. andrea.alimonti@ior.usi.ch.
11 Università della Svizzera Italiana, CH6900, Lugano, Switzerland. andrea.alimonti@ior.usi.ch.
12 Department of Health Sciences and Technology (D-HEST) ETH Zurich, 8093, Zurich, CH, Switzerland. andrea.alimonti@ior.usi.ch.
13 Department of Medicine & Veneto Institute of Molecular Medicine, University of Padova, Padova, Italy. andrea.alimonti@ior.usi.ch.